Guillermo Ortí - Concepedia

Author

Guillermo Ortí

Vall d'Hebron Hospital Universitari ORCID

Also Known As

Christelle Ferra Coll, G Muñoz Orti, G Orti, G Ortí, G. Orti, Guillermo Orti, Guillermo OrtÍ, Guillermo Ortí, Guiomar Bautista Carrascosa, Orti, G

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Hospital Universitari i Politècnic La Fe University College London Hospital de Sant Pau

About

Guillermo Ortí is an author at Vall d'Hebron Hospital Universitari specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	458
2	Blood Transplantation	5	5	176
3	Cellular Therapies	4	4	71
4	Health Sciences	1	1	20
5	Cell Biology	1	1	21

Guillermo Ortí

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model Pau Montesinos, I Di Lorenzo, Jaime Sanz, Haematologica	2007	216
Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients Carolina García‐Vidal, Pere Barba, Montserrat Arnán, Clinical Infectious Diseases Invasive AspergillosisPathogenesisImmunologyPathologyClinical Mycology	2011	105
Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients Jaime Sanz, F Arriaga, Pau Montesinos, Bone Marrow Transplantation TransplantationAutoimmune DiseaseMarrow TransplantationBone Marrow FailureAdult Patients	2007	99
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution Ronjon Chakraverty, Guillermo Ortí, Jun Shen, Blood	2010	93
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico Guillermo Ortí, Jaime Sanz, Arancha Bermúdez, Biology of Blood and Marrow Transplantation	2015	61
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning Adam J. Mead, Kirsty Thomson, Emma Morris, Blood	2010	58
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Moraima Jiménez, Elisa Roldán, Candela Fernández‐Naval, Blood Advances	2021	58
Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease Irene García‐Cadenas, I Rivera, Rodrigo Martino, Bone Marrow Transplantation TransplantationInfectionInfection-related MortalityHealthcare-associated InfectionClinical Epidemiology	2016	57
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab Irene García‐Cadenas, Nerea Castillo, Rodrigo Martino, Bone Marrow Transplantation Lymphoid NeoplasiaHigh-risk Allo-sctAutoimmune DiseaseImmunodeficienciesImmunology	2015	55
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies Jaime Sanz, Juan Montoro, Carlos Solano, Biology of Blood and Marrow Transplantation	2019	49

Page 1